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We describe a patient with solitary lymph node (LN) metastasis after three endoscopic mucosal resections (EMRs)
in which a gastrointestinal stromal tumor was difficult to differentiate from the carcinoid and lymphoma tumors.
A 77-year-old man underwent three EMRs at 62, 72, and 75 years of age, and all resections were determined to
be curative. However, 2 years after the last EMR, screening abdominal ultrasonography detected a 20-mm solitary
tumor at the lesser curvature of the upper stomach. Laparoscopic tumor resection confirmed the pathological
diagnosis. Intraoperative pathological diagnosis showed that the adenocarcinoma was compatible with recurrence
of gastric cancer; thus, total gastrectomy with D1 lymphadenectomy was performed. Metastasis was not recognized
by pathological examination but was detected by preoperative radiological examinations of the LN. We report a
rare recurrence case after several EMRs of intramucosal gastric cancers.
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In Japan, the Gastric Cancer Treatment Guidelines (GCTGs)
(ver. 3) define absolute indications for endoscopic resec-
tion (ER), which include ≤20-mm intramucosal differenti-
ated cancers without an ulcer [1]. Curative resection is
restricted to en bloc resection in the latest guideline
[1]. However, before the GCTGs were established, piece-
meal resection was considered to be curative when the
specimen was completely reconstructed and showed nega-
tive lymphovascular invasions and horizontal/vertical
margins [2]. We experienced a rare late recurrence case
of lymph node (LN) metastasis after endoscopic mucosal
resections (EMRs) including a piecemeal resection that
were curative on the basis of the GCTGs criteria at that
time [1-3].* Correspondence: tsunehiro-t@a8.keio.jp
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A 62-year-old man was admitted in 1998 because early
gastric cancer (EGC) was detected by annual screening
endoscopy. There was no specific finding in the physical
examination or laboratory data. He had no medical his-
tory of malignant tumors. The lesion was a 10-mm type
0-IIc moderately differentiated adenocarcinoma without
an ulcer located at the lesser curvature of the antrum
(Figure 1a). We diagnosed that this lesion had a negli-
gible risk of LN metastasis, and ER was indicated [4].
We explained to the patient that EMR was an investiga-
tional treatment at that time, and he chose to receive
EMR instead of surgery. EMR using piecemeal resection
was performed, which was curative macroscopically. The
specimens were completely reconstructed, and patho-
logical examination confirmed a 10-mm type 0-IIc mod-
erately differentiated adenocarcinoma, without an ulcer
(Figure 1b). The tumor was confined to the mucosa with
negative lymphovascular invasions and horizontal/vertical
margins, which indicated that the resection was curative
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Figure 1 Endoscopic and pathological findings of three endoscopic mucosal resections (EMRs). (a, b) Endoscopy showed a type 0-IIc
lesion 10 mm in size without an ulcer on the lesser curvature of the antrum in 1998 (a). Pathological examination revealed moderately
differentiated adenocarcinoma in the intramucosal proximal portion of the lesion (b). (c, d) Endoscopy showed a type 0-IIa lesion 12 mm
in size without an ulcer on the anterior wall near the pylorus in 2008 (c). Pathological examination revealed predominantly moderately
differentiated adenocarcinoma with papillary adenocarcinoma component in the intramucosal proximal portion of the lesion (d). (e, f) Endoscopy
showed a type 0-IIa + IIc lesion 7 mm in size without an ulcer on the greater curvature of the antrum in 2011 (e). Pathological examination revealed
moderately differentiated adenocarcinoma remaining in the muscularis mucosa (f).
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3, and 6 months after EMR to check for local recurrence,
and every biopsy of the EMR scars revealed no malig-
nancy. Thereafter, we performed follow-up endoscopy and
abdominal ultrasonography (AUS) to check locoregional
or distant metastasis every year, and no recurrence was
detected. After 10 years, another lesion was detected by
endoscopy in 2008 when the patient was 72 years old. The
lesion was a 12-mm type 0-IIa moderately differentiatedadenocarcinoma without an ulcer located at the anterior
wall near the pylorus (Figure 1c). En bloc EMR was per-
formed; pathological examination revealed a 12-mm type
0-IIa lesion without an ulcer that was predominantly a
moderately differentiated adenocarcinoma with papillary
adenocarcinoma components (Figure 1d). The tumor was
confined to the mucosa with negative lymphovascular
invasions and horizontal/vertical margins, which indi-
cated that the resection was curative according to the
a b c
Figure 2 Abdominal ultrasonography (AUS), computed tomography (CT) and positron emission tomography-computed tomography
(PET-CT) findings of the tumor. (a) Abdominal ultrasonography showed the tumor 20 mm in size along the lesser curvature of the stomach.
(b) CT scan showed the tumor 20 mm in size at the same lesion. (c) PET-CT showed an FDG hot uptake at the same lesion.
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endoscopy and AUS every year; recurrence was not
observed, but a nonrecurrent lesion was detected in 2011
when the patient was 75 years old. The lesion was a 7-mm
type 0-IIa + IIc moderately differentiated adenocarcinoma
without an ulcer, located at the greater curvature of the
antrum (Figure 1e). En bloc EMR was performed; patho-
logical examination revealed a 1-mm moderately differen-
tiated adenocarcinoma without an ulcer (Figure 1f). The
tumor was confined to the mucosa with negative lympho-
vascular invasions and horizontal/vertical margins. How-
ever, the tumor seemed to invade into the muscularisa
c
Figure 3 Endoscopic findings of three endoscopic mucosal resection
EMR scar on the lesser curvature of the antrum (a), the second EMR scar o
curvature of the antrum (c), and an elevated lesion displaced from the outmucosa, which indicated that the resection was curative
(GCTGs, ver. 3) [1]. Although subsequent endoscopy did
not detect recurrence, a 20-mm tumor was detected along
the lesser curvature of the stomach by screening AUS in
2013 when the patient was 77 years old (Figure 2a). We
performed computed tomography (CT) and positron
emission tomography (PET)-CT. CT showed a 20-mm
tumor along the lesser curvature of the stomach and no
other metastatic lesion (Figure 2b). PET-CT showed
18 F-fluorodeoxyglucose hot uptake in the same lesion
(Figure 2c). We performed endoscopy to check for new
lesions or local recurrence. The endoscopy showed threeb
d
(EMR) scars and an elevated lesion. Endoscopy showed the first
n the anterior wall near the pylorus (b), last EMR scar on the greater
side at the lesser curvature of the upper stomach (d).
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from the outside at the lesser curvature of the upper
stomach that had not been detected at the last endoscopy
(Figure 3a-d). We performed biopsies of each EMR scar
and the elevated lesion, but no malignancy was iden-
tified. Gastrointestinal stromal tumor (GIST), carcinoid
tumor, and lymphoma were considered in the differential
diagnosis along with LN metastasis. Although endo-
scopic ultrasound (EUS)-guided fine-needle aspiration
(FNA) was considered to determine a pathological diagno-
sis, EUS-FNA was not performed because of the risk of
dissemination. We performed a laparoscopic total exci-
sional biopsy to resect the tumor, and the intraoperative
frozen section indicated LN metastasis of the adenocar-
cinoma (Figure 4a). Because this LN was recognized
as #3a LN with stomach invasion, the operation was con-
verted to an open standard total gastrectomy with D1
LN dissection. Postoperative pathological examination
indicated that the resected LN was a metastasis of the
moderately differentiated adenocarcinoma with stomach
wall invasion (Figure 4b-d). Additionally, no remnant or
recurrent malignancy was detected at any stomach EMR
site, and no other metastasis was found among the 52
other LNs retrieved.a
c
Figure 4 Intraoperative laparoscopic and postoperative pathological
located along the lesser curvature of the upper stomach. (b) Resected tum
pathological examination revealed that the resected LN was compatible w
had invaded the stomach wall (d).Discussion
Currently, indications for endoscopic treatment of gastric
cancer are based on retrospective analysis of the incidence
of lymph node metastasis [5]. The GCTGs (ver. 3) define
absolute indications for ER, which include ≤20-mm intra-
mucosal differentiated cancers without an ulcer [1]. When
the first EMR was performed, there were no guidelines for
gastric cancer treatment, and definitive indications for
endoscopic treatment had not been established. However,
in our case, a retrospective analysis showed that there was
a negligible risk of LN metastasis, and the lesion was con-
sidered to be suitable for endoscopic treatment [4]. The
first EMR involving piecemeal resection initially consid-
ered to be curative was later considered to have been an
incomplete resection [1,2]. However, incomplete resection
only caused by piecemeal resection need not always
require additional surgery [1]. Horiki et al. reported that
piecemeal EMR elevated the risk of local recurrence but
not of LN metastasis [6]. Because evaluation of horizontal
margins is extremely important in EMR, en bloc resection
is necessary, and endoscopic submucosal dissection (ESD)
would be superior for the evaluation of horizontal mar-
gins. Although ESD has been widely performed, only a few
cases of metastasis have been reported after endoscopicb
d
findings. (a) Laparoscopic findings of an enlarged lymph node (LN)
or with LN metastasis invading the stomach wall. (c, d) Postoperative
ith metastasis of moderately differentiated adenocarcinoma (c) and
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[7-9]. Because cases of LN metastasis after curative ERs
and solitary LN metastasis are rare, we considered GIST,
carcinoid tumor, and lymphoma in the differential diagno-
sis along with LN metastasis. Although it might be pos-
sible to confirm the pathological diagnosis by EUS-FNA,
its sensitivity and specificity in patients with lymphaden-
opathy suspected of recurrent malignancy is low and has
a risk of dissemination in the case of extrinsic tumors.
Hence, we performed laparoscopic surgery to resect the
tumor as a total excisional biopsy [10]. In the present
case, we performed three EMRs, and every pathological
examination revealed moderately differentiated adenocar-
cinoma, which indicates that it is difficult to patho-
logically predict the primary tumor of metastatic LN.
It was possible that LN metastasis rose from the last
EMR lesion because the tumor seemed to invade into
the muscularis mucosa. However, in gastric cancers, the
risk of LN metastasis from the muscularis mucosa is
lower than that of esophageal cancers [1,11,12]. Given
that the first EMR was a piecemeal resection, this
lesion was thought to be the original one. However, if
this lesion caused the LN metastasis, this case is
especially unique because the metastasis was detected
15 years after the EMR. Although the piecemeal
resection was considered to have elevated the risk of
local recurrence but not of LN metastasis, it was con-
sidered to have contributed to the very slow LN me-
tastasis [6]. Our case might represent a limitation of
ER in evaluating LN status. This viewpoint is consist-
ent with a recent guideline in which piecemeal resec-
tion is considered to be incomplete [1].
Conclusions
This case presents a rare case of late LN metastasis after
EMR based on the indications for endoscopic treatment
of gastric cancer. This case might represent a limitation
of ER in evaluating LN status. Because piecemeal resec-
tion has a risk of not only local recurrence but also of
LN metastasis, en block resection is required, and care-
ful follow-up is mandatory.
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